LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Accueil・Liste d'Actions・Moderna Inc

Moderna Inc

Ouvert

Secteur Soins de santé

53.66 -1.52

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

53.34

Max

55.56

Chiffres clés
By Trading Economics
Revenu	-104M -1.3B
Ventes	-167B 241M
P/E Moyenne du Secteur	35.86 104.138
BPA	-3.33
Marge bénéficiaire	-530.705
Employés	5,600
EBITDA	-109M -1.2B

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+70.24 upside

Dividendes
By Dow Jones
Prochains Résultats	7 nov. 2024

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	522M 21B
Ouverture précédente	55.18
Clôture précédente	53.66

Sentiment de l'Actualité

By Acuity

100%

373 / 390 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

53.05 / 54.76 Support & Résistance

Moderna Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

13 déc. 2023, 13:16 UTC

Principaux Mouvements du Marché

Moderna Shares, Other Covid Vaccine Makers Hit by Warning From Pfizer

3 nov. 2024, 23:34 UTC

Actualités

Stocks Poised for Lower Open -- Barrons.com

28 oct. 2024, 13:48 UTC

Résultats

Moderna's Stock-Price Target Slashed. It's About Vaccines. -- Barrons.com

15 sept. 2024, 07:00 UTC

Actualités

World's Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna -- Barrons.com

12 sept. 2024, 15:02 UTC

Actualités

Moderna Cost Cuts Fail to Restore Investor Trust -- Heard on the Street -- WSJ

12 sept. 2024, 10:00 UTC

Actualités

Moderna Pulls Back on R&D and Delays Timeline for Profitability -- Barrons.com

6 sept. 2024, 11:00 UTC

Actualités

Pandemic Darling Moderna Needs a Reality Check -- Heard on the Street -- WSJ

3 sept. 2024, 04:00 UTC

Actualités

Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring -- Barrons.com

23 août 2024, 18:38 UTC

Actualités

The U.S. Is Bringing Back Free Covid Tests This Fall -- Barrons.com

2 août 2024, 21:29 UTC

Actualités

The Score: CrowdStrike, Apple, Intel and More Stocks That Defined the Week -- WSJ

1 août 2024, 10:30 UTC

Actualités

Moderna Cuts Revenue Guidance Amid Steeper Competition -- Barrons.com

3 juil. 2024, 14:18 UTC

Acquisitions, Fusions, Rachats

GSK Will Pay Up to $1.5 Billion for CureVac's mRNA Vaccines -- Barrons.com

30 mai 2024, 19:45 UTC

Actualités

Bird Flu Confirmed in Third Farmworker. It's the First Case With Respiratory Symptoms. -- Barrons.com

29 mai 2024, 15:56 UTC

Résultats

Acquisitions, Fusions, Rachats

The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why. -- Barrons.com

10 mai 2024, 20:11 UTC

Résultats

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

10 mai 2024, 14:49 UTC

Résultats

Actions en Tendance

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

2 mai 2024, 13:46 UTC

Résultats

Actions en Tendance

Stocks to Watch Thursday: Carvana, NIO, Qualcomm, Peloton -- WSJ

2 mai 2024, 10:31 UTC

Résultats

Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout? -- IBD

2 mai 2024, 09:08 UTC

Actions en Tendance

Stocks to Watch Thursday: Shell, Novo Nordisk, Apple -- WSJ

28 févr. 2024, 14:14 UTC

Résultats

Novavax Stock Sinks as Revenue Misses Estimates in 'Transition Year' -- Barrons.com

22 févr. 2024, 16:00 UTC

Actualités

Moderna Is Pivoting From Covid and the Results Are on Their Way -- Heard on the Street -- WSJ

22 févr. 2024, 12:40 UTC

Résultats

Moderna Stock Jumps on Surprise Profit After Earnings Beat. What to Expect in 2024. -- Barrons.com

Comparaison

Variation de prix

Moderna Inc prévision

Objectif de Prix

By TipRanks

70.24% hausse

Prévisions sur 12 Mois

Moyen 93 USD 70.24%

Haut 238 USD

Bas 46 USD

Basé sur 19 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

19 ratings

Achat

Maintien

Vente

Basé sur 19 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

53.05 / 54.76Support & Résistance

All events are bullish.

All events are bearish.

Sentiment

By Acuity

373 / 390Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Moderna Inc

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.